The General Motors charity car show was held on Sunday in Cheshire, benefitting families with children diagnosed with Angelman Syndrome. Angelman Syndrome affects one in ...

The initial participant in the pivotal Phase 3 REVEAL trial, which is assessing ION582 for Angelman syndrome, a severe neurodevelopmental disease, has been dosed by Ionis Pharmaceuticals, Inc ...

Angelman syndrome is a genetic disorder causing developmental delays, speech issues, balance problems, seizures, and frequent smiling and laughter.

A woman surrendered her infant at Simpson General Hospital's Safe Haven Baby Box — Mississippi's second Baby Box surrender. In January 2024, Simpson General Hospital in Mendenhall opened its Safe ...

The agency’s commissioner has implied that some of their ingredients may be harmful. Is that true?

NEW YORK – Ionis Pharmaceuticals has treated the first patient in a Phase III clinical trial evaluating the efficacy and safety of its investigational antisense oligonucleotide (ASO) therapy for ...

"Dosing the first person with Angelman syndrome in our pivotal REVEAL study marks an important milestone for this underserved community, who currently have no approved disease modifying treatments ...

A new review sheds light on the complex molecular mechanisms behind Angelman syndrome (AS), a rare neurogenetic disorder, and explores how cutting-edge gene-targeting therapies may offer more ...

What is Angelman syndrome? Angelman syndrome is a rare genetic condition that affects the nervous system and causes severe physical and learning disabilities, according to the NHS.

Colin Farrell has made the hard decision to put his 21-year-old son James, who suffers from Angelman syndrome, in a long-term care facility.

James Farrell has Angelman syndrome.Colin Farrell Son James, 21, to Be Placed in Long-Term Care Facility ...